Lisa Pickering discusses the 2 randomised trial and the 1st line combination study in renal cancer

Episode 271: ESMO 2023 - THOR: Erdafitinib in bladder cancer

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London